Sean M Bagshaw Selected Research

Acute Kidney Injury (Acute Renal Failure)

2/2022	Improving the quality of the performance and delivery of continuous renal replacement therapy (CRRT) to critically ill patients across a healthcare system: QUALITY CRRT: a study protocol.
12/2021	Timing of renal-replacement therapy in intensive care unit-related acute kidney injury.
6/2021	Intra-dialytic hypotension following the transition from continuous to intermittent renal replacement therapy.
5/2021	Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis.
4/2021	Starting Kidney Replacement Therapy in Critically III Patients with Acute Kidney Injury.
1/2021	Association Between Acute Kidney Injury Duration and Outcomes in Critically Ill Children.
1/2021	External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury.
1/2021	Timing of kidney replacement therapy initiation in acute kidney injury.
1/2021	When should we start renal-replacement therapy in critically ill patients with acute kidney injury: do we finally have the answer?
1/2021	Short-and long-term outcomes of sustained low efficiency dialysis vs continuous renal replacement therapy in critically ill patients with acute kidney injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sean M Bagshaw Research Topics

Disease

117	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 08/2004
108	Critical Illness (Critically Ill) 04/2022 - 03/2003
30	Sepsis (Septicemia) 10/2018 - 02/2005
18	Frailty 01/2021 - 01/2011
13	Septic Shock (Toxic Shock Syndrome) 10/2018 - 01/2005
12	Infections 11/2022 - 02/2006
11	Chronic Renal Insufficiency 01/2021 - 08/2004
7	Hemorrhage 11/2022 - 01/2006
6	Hypotension (Low Blood Pressure) 06/2021 - 05/2009
6	Heart Failure 10/2020 - 09/2007
5	COVID-19 01/2022 - 01/2021
5	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 09/2006
5	Shock 10/2018 - 10/2005
5	Renal Insufficiency (Renal Failure) 02/2016 - 05/2007
5	Fibrosis (Cirrhosis) 04/2014 - 12/2010
4	Delirium 06/2022 - 12/2017
4	Anemia 01/2021 - 03/2015
4	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 10/2013
4	Bacteremia 02/2018 - 04/2015
4	Acidosis 02/2014 - 08/2004
4	Rhabdomyolysis 07/2011 - 01/2007
3	Ulcer 11/2022 - 09/2018
3	Clostridium Infections 11/2022 - 04/2015
3	Kidney Diseases (Kidney Disease) 01/2022 - 12/2014
3	Pain (Aches) 01/2021 - 01/2019
3	Cardio-Renal Syndrome 10/2020 - 11/2010
3	Body Weight (Weight, Body) 12/2017 - 05/2007
3	Necrosis 09/2017 - 01/2007
3	End Stage Liver Disease 07/2015 - 04/2014
3	Death (Near-Death Experience) 07/2015 - 02/2009
3	Disease Progression 12/2014 - 12/2007
3	Liver Diseases (Liver Disease) 07/2014 - 01/2005
3	Pulmonary Edema 07/2012 - 01/2007
2	Diabetes Mellitus 01/2021 - 04/2014
2	Heart Diseases (Heart Disease) 10/2020 - 01/2011
2	Wounds and Injuries (Trauma) 01/2019 - 10/2007
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2009
2	Venous Thromboembolism 01/2019 - 01/2019
2	Stroke (Strokes) 10/2018 - 11/2006
2	Seizures (Absence Seizure) 10/2018 - 02/2009
2	Coinfection 02/2018 - 04/2015

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2007
16	CreatinineIBA 01/2021 - 09/2006
7	AlbuminsIBA 01/2019 - 10/2007
5	Urea (Carbamide)FDA LinkGeneric 01/2017 - 08/2004
4	DiureticsIBA 10/2020 - 01/2007
4	Polymyxin B (Aerosporin)FDA LinkGeneric 10/2018 - 11/2016
4	Saline SolutionIBA 01/2016 - 05/2012
4	SodiumIBA 02/2015 - 02/2009
3	Proton Pump InhibitorsIBA 11/2022 - 09/2018
3	IronIBA 01/2021 - 01/2007
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020 - 01/2014
3	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 06/2005
3	Citric Acid (Citrate)FDA LinkGeneric 10/2020 - 06/2005
3	PotassiumIBA 07/2019 - 07/2012
3	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 07/2019 - 01/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2018 - 04/2015
3	Furosemide (Lasix)FDA LinkGeneric 01/2018 - 05/2010
3	Lipocalin-2IBA 12/2015 - 03/2010
3	Bicarbonates (Hydrogen Carbonate)IBA 02/2015 - 01/2013
3	Pharmaceutical PreparationsIBA 02/2014 - 05/2003
3	Colloids (Colloid)IBA 02/2014 - 10/2007
3	Starch (Cornstarch)IBA 07/2013 - 01/2009
3	Blood Glucose (Blood Sugar)IBA 07/2009 - 01/2009
2	Phosphates (Orthophosphate)IBA 04/2022 - 01/2017
2	VaccinesIBA 11/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2019
2	ChemokinesIBA 01/2021 - 11/2012
2	Insulin (Novolin)FDA Link 07/2019 - 01/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 01/2019
2	Vasodilator Agents (Vasodilators)IBA 10/2018 - 12/2017
2	EndotoxinsIBA 10/2018 - 01/2018
2	boldenone undecylenate (Equipoise)IBA 02/2018 - 05/2010
2	Tissue Inhibitor of Metalloproteinase-2IBA 01/2018 - 10/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 11/2012
2	Insulin-Like Growth Factor Binding ProteinsIBA 01/2018 - 10/2016

Therapy/Procedure

63	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 09/2006
39	Critical Care (Surgical Intensive Care) 11/2022 - 02/2005
36	Therapeutics 11/2022 - 05/2003
30	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2005
19	Length of Stay 11/2022 - 02/2006
19	Continuous Renal Replacement Therapy 02/2022 - 01/2005
16	Resuscitation 01/2019 - 10/2005
10	Renal Dialysis (Hemodialysis) 05/2021 - 08/2004
9	Fluid Therapy (Oral Rehydration Therapy) 04/2018 - 12/2006
7	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018 - 01/2007
7	Liver Transplantation 07/2015 - 01/2009
4	Mechanical Ventilators (Ventilator) 11/2022 - 10/2007
4	Tracheostomy 12/2019 - 01/2006
4	Hemofiltration 01/2014 - 11/2010
3	Intermittent Renal Replacement Therapy 06/2021 - 12/2006
3	Blood Transfusion (Blood Transfusions) 01/2021 - 05/2012
3	Long-Term Care 01/2020 - 01/2019
3	Hemoperfusion 10/2018 - 01/2018
3	Duration of Therapy 02/2018 - 04/2015
3	Glycemic Control 02/2010 - 02/2009
2	Catheters 01/2021 - 07/2014
2	Highly Active Antiretroviral Therapy (HAART) 10/2019 - 01/2017
2	Erythrocyte Transfusion 01/2019 - 01/2018
2	Patient Readmission 01/2019 - 12/2014